Ultralife Net Receivables from 2010 to 2026

ULBI Stock  USD 6.53  0.19  3.00%   
Ultralife's Net Receivables is increasing with slightly volatile movements from year to year. Net Receivables is estimated to finish at about 35.5 M this year. For the period between 2010 and 2026, Ultralife, Net Receivables quarterly trend regression had mean deviation of  7,579,495 and range of 34.9 M. View All Fundamentals
 
Net Receivables  
First Reported
1992-06-30
Previous Quarter
32.3 M
Current Value
30.9 M
Quarterly Volatility
11.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Ultralife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultralife's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Interest Expense of 1.3 M or Total Revenue of 198.6 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0 or PTB Ratio of 1.99. Ultralife financial statements analysis is a perfect complement when working with Ultralife Valuation or Volatility modules.
  
Build AI portfolio with Ultralife Stock
Check out the analysis of Ultralife Correlation against competitors.
For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.
The Net Receivables trend for Ultralife offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Ultralife is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Ultralife's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Ultralife over the last few years. It is Ultralife's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ultralife's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Ultralife Net Receivables Regression Statistics

Arithmetic Mean20,724,634
Geometric Mean16,667,018
Coefficient Of Variation45.97
Mean Deviation7,579,495
Median20,232,000
Standard Deviation9,526,958
Sample Variance90.8T
Range34.9M
R-Value0.83
Mean Square Error30.8T
R-Squared0.68
Significance0.000044
Slope1,558,144
Total Sum of Squares1452.2T

Ultralife Net Receivables History

202635.5 M
202533.8 M
202429.4 M
202331.8 M
202227.8 M
202120.2 M
202021.1 M

About Ultralife Financial Statements

Investors use fundamental indicators, such as Ultralife's Net Receivables, to determine how well the company is positioned to perform in the future. Although Ultralife's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Receivables33.8 M35.5 M

Currently Active Assets on Macroaxis

When determining whether Ultralife offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ultralife's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ultralife Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ultralife Stock:
Check out the analysis of Ultralife Correlation against competitors.
For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is there potential for Electrical Components & Equipment market expansion? Will Ultralife introduce new products? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Earnings Share
0.1
Revenue Per Share
11.212
Quarterly Revenue Growth
0.215
Return On Assets
0.0223
Ultralife's market price often diverges from its book value, the accounting figure shown on Ultralife's balance sheet. Smart investors calculate Ultralife's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Ultralife's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.